TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO. Stock

Certificat

DE000SW5P5P5

Market Closed - Boerse Frankfurt Warrants 15:35:39 2024-05-24 EDT
0.43 EUR +38.71% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO.
Current month-10.42%
1 month-32.81%
Date Price Change
24-05-24 0.43 +38.71%
24-05-23 0.31 +6.90%
24-05-22 0.29 -12.12%
24-05-21 0.33 +17.86%
24-05-20 0.28 -9.68%

Real-time Boerse Frankfurt Warrants

Last update May 24, 2024 at 03:35 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SW5P5P
ISINDE000SW5P5P5
Date issued 2024-03-27
Strike 133.8 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.87
Lowest since issue 0.095

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5 USD
Average target price
141.9 USD
Spread / Average Target
+9.57%
Consensus